The IMC DLBCL lymph node section was split by high and low Ki-67 expression to identify the highly proliferative tumor cells (Figure 5A); Ki-67 is used as a prognostic marker in DLBCL (Tang et al., 2017). This evidence concerns the gene MKI67 and diffuse large B-cell lymphoma.